20/20 BIOLABS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2025-02-26: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-01-21; Total offering amount $3,000,000.
- 2016-02-19: Federal exemption Rule 506(c); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2014-10-31; Total offering amount $4,000,000.
- 2015-10-30: Federal exemption Rule 506(c); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2014-10-31; Total offering amount $4,000,000.
- 2015-09-22: Federal exemption Rule 506(c); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2014-10-31; Total offering amount $4,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2025-02-26 | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired | 2025-01-21 | $3,000,000 | $70,000 | $2,930,000 | 3 |
| 2016-02-19 D/A | Rule 506(c) | Equity; OptionToAcquire; SecurityToBeAcquired | 2014-10-31 | $4,000,000 | $2,513,413 | $1,486,587 | 66 |
| 2015-10-30 D/A | Rule 506(c) | Equity; OptionToAcquire; SecurityToBeAcquired | 2014-10-31 | $4,000,000 | $2,158,413 | $1,841,587 | 49 |
| 2015-09-22 | Rule 506(c) | Equity; OptionToAcquire; SecurityToBeAcquired | 2014-10-31 | $4,000,000 | $2,037,014 | $1,962,986 | 45 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |